Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. - Toole,J.F.; Malinow,M.R.; Chambless,L.E. (Jama, 2004)